Back to search

Article

Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review of 2010-2020

2022-02-21

Abstract excerpt

<title>Abstract</title> <p>Background: Osteosarcoma is the most common bone tumor in children and adolescents. Despite multiagent chemotherapy, only 71% of patients survives and these survivors often experience long-term toxicities. The main objective of this systematic review is to provide an overview of the discovery of novel associations of germline polymorphisms with treatment response and/or chemotherapy-ind...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6dacae8-6fdb-5de9-850f-8f5ed50d0167
DOI
10.21203/rs.3.rs-1113738/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review of 2010-2020DOI 10.21203/rs.3.rs-1113738/v1
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.Semantic proximity
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.Semantic proximity
Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.Semantic proximity
The role of pharmacogenetics in the treatment of osteosarcomaSemantic proximity
CYP Genotypes Are Associated with Toxicity and Survival in Osteosarcoma Patients.Semantic proximity
From Genes to Personalized Cancer Care: A Systematic Review of Toxicity-Associated Genetic Variants in Solid Tumor TreatmentsSemantic proximity
Genomic and Transcriptomic Characterization of Pre-operative Chemotherapy Response in Patients with OsteosarcomaSemantic proximity
A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment.Semantic proximity
Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.Semantic proximity
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 ProtocolSemantic proximity
Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity.Semantic proximity
Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.Semantic proximity
Select a neighboring publication to make it the new centre.